A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in many kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research